D. Guétard

发表

HIV-1 Genome Nuclear Import Is Mediated by a Central DNA Flap

Luc Montagnier, L. Montagnier, P. Charneau, 2000, Cell.

Lentivirus-mediated gene transfer in primary T cells is enhanced by a central DNA flap

N. Taylor, P. Charneau, D. Guétard, 2001, Gene Therapy.

Isolation of a new human retrovirus from West African patients with AIDS.

F. Brun-Vézinet, C. Katlama, S. Chamaret, 1986, Science.

T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV

Luc Montagnier, David Klatzmann, Eric Champagne, 1984, Nature.

Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors.

P. Charneau, Véronique Zennou, D. Guétard, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

Programmed cell death in AIDS-related HIV and SIV infections.

J. Heeney, C. Dauguet, L. Montagnier, 1993, AIDS research and human retroviruses.

Specificity of antipeptide antibodies produced against V2 and V3 regions of the external envelope of human immunodeficiency virus type 2.

L. Montagnier, S. Benichou, D. Guétard, 1994, Molecular immunology.

Oxidative protein damage and degradation in lymphocytes from patients infected with human immunodeficiency virus.

L. Montagnier, M. Magnani, G. Silvestri, 1997, The Journal of infectious diseases.

Prevention of early cell death in peripheral blood lymphocytes of HIV infected individuals by an anti-oxidant: N-Acetyl-Cysteine

L. Montagnier, D. Guétard, T. Dragic, 1994 .

Intracellular location of the two small RNA coded by Epstein-Barr virus genome and their variations according to viral expression

L. Montagnier, D. Guétard, H. Collandre, 1984 .

Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis

L. Montagnier, D. Guétard, E. Fenouillet, 1989, The Journal of experimental medicine.

Effect of alpha-1 antitrypsin Portland variant (alpha 1-PDX) on HIV-1 replication.

N. Seidah, M. Bendjennat, D. Guétard, 2000, The Biochemical journal.

[Infectivity inhibition of HIV prototype strains by antibodies directed against a peptide sequence of mycoplasma].

S. Chamaret, L. Montagnier, D. Guétard, 1990, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

Oral administration of low doses of plant-based HBsAg induced antigen-specific IgAs and IgGs in mice, without increasing levels of regulatory T cells.

S. Wain-Hobson, D. Guétard, T. Pniewski, 2009, Vaccine.

HIV-2 in rhesus monkeys: serological, virological and clinical results.

D. Dormont, B. Larke, S. Chamaret, 1989, Intervirology.

Random cleavage of intranuclear herpes simplex virus DNA by micrococcal nuclease

D. Guétard, J. Bechet, M. Mouttet, 1979, FEBS letters.

In vitro sensitivity of human herpesvirus-6 to antiviral drugs.

H. Agut, L. Montagnier, V. Favier, 1989, Research in virology.

Induction of anti-human immunodeficiency virus (HIV) neutralizing antibodies in rabbits immunized with recombinant HIV--hepatitis B surface antigen particles.

V. Favier, D. Guétard, E. Bahraoui, 1988, Proceedings of the National Academy of Sciences of the United States of America.

CONCOMITANT INFECTION BY HUMAN HERPESVIRUS 6, HTLV-I, AND HIV-2

H. Agut, C. Dauguet, L. Montagnier, 1988, The Lancet.

RIBAVIRIN IN HTLV-III:LAV INFECTION OF INFANTS

A. Fischer, F. Deist, C. Griscelli, 1986, The Lancet.

Study of the interaction of HIV-1 and HIV-2 envelope glycoproteins with the CD4 receptor and role of N-glycans.

L. Montagnier, H. Kolbe, D. Guétard, 1992, AIDS research and human retroviruses.

Atypical HIV serological profile of novel HIV-1 variant distinct from subtype O

S. Chamaret, L. Montagnier, D. Guétard, 1995, The Lancet.

Spermatozoa as potential carriers of HIV.

C. Dauguet, L. Montagnier, D. Guétard, 1993, Research in virology.

Abnormal intracellular kinetics of cell-cycle-dependent proteins in lymphocytes from patients infected with human immunodeficiency virus: a novel biologic link between immune activation, accelerated T-cell turnover, and high levels of apoptosis.

M. Magnani, G. Silvestri, M. Paiardini, 2001, Blood.

Characterization of an HIV-2-related virus with a smaller sized extracellular envelope glycoprotein.

L. Montagnier, D. Guétard, A. Laurent, 1989, Virology.

LAV revisited: origins of the early HIV-1 isolates from Institut Pasteur.

R. Cheynier, S. Wain-Hobson, J. Vartanian, 1991, Science.

Production of recombinant HIV-1/HBV virus-like particles in Nicotiana tabacum and Arabidopsis thaliana plants for a bivalent plant-based vaccine.

S. Wain-Hobson, D. Guétard, F. Sala, 2007, Vaccine.

Massive APOBEC3 Editing of Hepatitis B Viral DNA in Cirrhosis

V. Mazzaferro, P. Pineau, A. Dejean, 2010, PLoS pathogens.

Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo.

S. Wain-Hobson, J. Vartanian, D. Guétard, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Genetic Editing of HBV DNA by Monodomain Human APOBEC3 Cytidine Deaminases and the Recombinant Nature of APOBEC3G

S. Wain-Hobson, J. Vartanian, D. Guétard, 2009, PloS one.

Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo.

M. Sitbon, S. Wain-Hobson, J. Vartanian, 2009, Journal of molecular biology.

Adaptation of lymphadenopathy associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines.

J. Chermann, F. Barré-Sinoussi, M. Nugeyre, 1984, Science.

Immunogenicity and tolerance following HIV-1/HBV plant-based oral vaccine administration.

S. Wain-Hobson, D. Guétard, F. Sala, 2008, Vaccine.

Human Tribbles 3 Protects Nuclear DNA from Cytidine Deamination by APOBEC3A*

P. Vidalain, S. Wain-Hobson, J. Vartanian, 2012, The Journal of Biological Chemistry.

Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism

P. Pineau, A. Dejean, S. Wain-Hobson, 2011, Proceedings of the National Academy of Sciences.

Inversing the natural hydrogen bonding rule to selectively amplify GC-rich ADAR-edited RNAs

S. Wain-Hobson, J. Vartanian, F. Tangy, 2008, Nucleic acids research.

Evidence for Editing of Human Papillomavirus DNA by APOBEC3 in Benign and Precancerous Lesions

S. Wain-Hobson, J. Vartanian, D. Guétard, 2008, Science.

APOBEC1 and APOBEC3 cytidine deaminases as restriction factors for hepadnaviral genomes in non-humans in vivo.

S. Wain-Hobson, J. Vartanian, D. Guétard, 2010, Journal of molecular biology.

Adult T-cell leukemia associated with HTLV-I and simultaneous infection by human immunodeficiency virus type 2 and human herpesvirus 6 in an African woman: A clinical, virologic, and familial serologic study

H. Agut, D. Guétard, A. Gessain, 1988 .

Differential cytotoxicity of tumour promoter TPA for EBV‐negative human lymphoma cell lines and their EBV‐converted sublines

D. Guétard, J. Bechet, 1983, International journal of cancer.

Antibodies to lav in various population groups of the Central African Republic

S. Chamaret, L. Montagnier, D. Guétard, 1985 .

Molecular Evidence for Nosocomial Transmission of Human Immunodeficiency Virus from a Surgeon to One of His Patients

Alain Blanchard, Luc Montagnier, L. Montagnier, 1998, Journal of Virology.

Human immunodeficiency virus infection and AIDS in a person with negative serology.

S. Chamaret, L. Montagnier, D. Guétard, 1997, The Journal of infectious diseases.

Human immunodeficiency virus type 2 infection associated with AIDS in West Africa.

S. Chamaret, L. Montagnier, V. Favier, 1987, The New England journal of medicine.

HIV-1 derived peptides fused to HBsAg affect its immunogenicity.

D. Guétard, T. Pniewski, A. Kostrzak, 2009, Virus research.

Isolation and envelope sequence of a highly divergent HIV-1 isolate: definition of a new HIV-1 group.

S. Chamaret, L. Montagnier, P. Charneau, 1994, Virology.

Human APOBEC1 cytidine deaminase edits HBV DNA

S. Wain-Hobson, J. Vartanian, D. Guétard, 2009, Retrovirology.

APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase.

Michel Henry, Peter Sommer, Simon Wain-Hobson, 2004, Nucleic acids research.

Molecular cloning and polymorphism of the human immune deficiency virus type 2

L. Montagnier, F. Clavel, D. Guétard, 1986, Nature.

Protease activation during HIV infection in a CD4-positive cell line.

L. Montagnier, V. Favier, G. Piedimonte, 1990, AIDS research and human retroviruses.

[Demonstration of an engagement process towards cell death by apoptosis in lymphocytes of HIV infected patients].

C. Dauguet, L. Montagnier, D. Guétard, 1991, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

Factors and Mechanisms of AIDS Pathogenesis1

C. Dauguet, L. Montagnier, D. Guétard, 1992 .

Clinical and virological aspects of HIV2 infection in rhesus monkeys.

H. Métivier, D. Dormont, S. Chamaret, 1992, Cancer Detection and Prevention.

Inhibition of in vitro HIV infection by trinitrophenyl-protein conjugates.

S. Avrameas, L. Montagnier, D. Guétard, 1995, Research in immunology.

Modulation of cell growth and host protein synthesis during HIV infection in vitro.

A. Di Rienzo, L. Montagnier, G. Piedimonte, 1992, Journal of Acquired Immune Deficiency Syndromes.

Exogenous Interleukin-2 Administration Corrects the Cell Cycle Perturbation of Lymphocytes from Human Immunodeficiency Virus-Infected Individuals

M. Magnani, G. Silvestri, M. Paiardini, 2001, Journal of Virology.

In vitro non-productive infection of purified natural killer cells by the BRU isolate of the human immunodeficiency virus type 1.

C. Dauguet, D. Scott‐Algara, D. Guétard, 1993, The Journal of general virology.

Protective activity of tetracycline analogs against the cytopathic effect of the human immunodeficiency viruses in CEM cells.

L. Montagnier, D. Guétard, A. Zerial, 1990, Research in virology.

Simian Immunodeficiency Virus Promoter Exchange Results in a Highly Attenuated Strain That Protects against Uncloned Challenge Virus

S. Wain-Hobson, D. Guétard, V. Monceaux, 2004, Journal of Virology.

Lack of HPA-23 antiviral activity in HIV-infected patients without AIDS.

C. Rouzioux, W. Rozenbaum, D. Guétard, 1989, AIDS.

Anti-termination by SIV Tat requires flexibility of the nascent TAR structure.

S. Wain-Hobson, J. Vartanian, M. Wachsmuth, 2004, Journal of molecular biology.

Double-Stranded RNA Adenosine Deaminase ADAR-1-Induced Hypermutated Genomes among Inactivated Seasonal Influenza and Live Attenuated Measles Virus Vaccines

S. Wain-Hobson, J. Vartanian, D. Guétard, 2010, Journal of Virology.

Search for infectious HIV in gingival crevicular fluid and saliva of advanced AIDS patients with severe periodontitis.

G. de Thé, D. Guétard, T. Suzuki, 1997, AIDS.

Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo.

S. Wain-Hobson, J. Vartanian, D. Guétard, 2005, Proceedings of the National Academy of Sciences of the United States of America.